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We studied experimental canine oral papillomavirus (COPV) infection by in situ hybridization and immunohistochemistry of
weekly biopsies. After 4 weeks, viral DNA in rete ridges suggested a keratinocyte stem cell target. Abundant viral DNA was
seen in E4-positive cells only. E4 was predominantly cytoplasmic but also nuclear, being concentrated in the nucleoli during
wart formation. Infected cells spread laterally along the basal layer and into the parabasal layers, accompanied by E7
transcription and increased mitoses. Most of the lower epithelium was positive for viral DNA, but, in mature warts, higher
levels of E4 expression and genome amplification occurred in only sporadic superficial cells. L1 expression was late and in
only a subset of E4-positive cells. During regression, viral DNA was less abundant in deep epithelial layers, suggesting
downregulation of replication prior to replacement of infected cells from beneath. Detection of viral DNA in post-regression
tissue indicated latent infection. © 2001 Academic Press
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The involvement of human papillomaviruses (HPVs) in
cancer of the cervix is well established with nearly all
cervical carcinomas containing HPV DNA (Walboomers
et al., 1999). Furthermore, 130 HPV types have been
cloned or identified by PCR detection of capsid (L1) DNA
(de Villiers, 1997), and certain “high-risk” HPV types have
been defined as carcinogens (Anonymous, 1996). Addi-
tionally, papillomaviruses cause a variety of benign tu-
mours of cutaneous and mucosal epithelia (Shah and
Howley, 1996), often responding poorly to a variety of
treatments (Beutner and Ferenczy, 1997). Persistence or
progression is common in people immunosuppressed as
a result of either HIV infection or organ transplantation
(Palefsky et al., 1998). In addition to the efforts currently
being made to find immunologically based prophylactic
or therapeutic strategies, it is clear from the diseases
seen in immunosuppressed individuals that there is a
need for nonimmunological treatments (Phelps et al.,
1998; Stanley et al., 1997). Such antiviral strategies re-
quire detailed knowledge of the papillomavirus life cycle.
The technical demands of in vitro culture of these vi-
ruses, and their species specificity, present difficulties in
examining the viral life cycle. Detailed chronological
analysis of the papillomavirus infectious cycle is impos-
1 To whom reprint requests should be addressed at present address:
ivision of Veterinary and Biomedical Sciences, Murdoch University,
outh Street, Murdoch, WA 6150, Australia. Fax: 161 8 9310 4144.
-mail: nicholls@numbat.murdoch.edu.au.
0042-6822/01 $35.00
Copyright © 2001 by Academic Press
All rights of reproduction in any form reserved.
82sible in human clinical material since the time of natu-
rally acquired infections is difficult to establish, making
the chronology of events in subsequent biopsies uncer-
tain. Because multiple sequential biopsies are rarely
justified on clinical grounds in the human patient, the
experimenter is left with only “snapshots” of the disease
taken from many different patients and lacking in coher-
ence. Although viral DNA and RNA have been examined
in biopsies of human clinical material (both warts and
neoplasms), similar studies of viral DNA and RNA in the
early stages of infection have not been possible because
the lesions become macroscopically detectable only af-
ter a period of several weeks, and there is a further delay
before patients present to clinics for examination and
treatment. These problems mean that although molecu-
lar biology has enabled great progress to be made in
understanding some of the details of virus-cell interac-
tions, there remain large gaps in the understanding of
papillomavirus biology. Animal models may help to over-
come some of these difficulties and have been cited as
an important standard to which in vitro and other model
systems should be compared (Chow and Broker, 1997).
To date, the rabbit and ox have been the most studied
naturally occurring animal models of papillomavirus in-
fection.
In the CRPV-infected rabbit, analysis of biopsies at
different times postinfection has provided important data
on the viral life cycle (Schmitt et al., 1996). However,
CRPV infection involves haired-skin, and there are im-
portant biological differences, especially with regard to
stem cell location, between haired (Cotsarelis et al.,
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83CANINE ORAL PAPILLOMAVIRUS LIFE CYCLE1990; Michel et al., 1996) and mucosal epithelia (Hume
nd Potten, 1983; Lavker and Sun, 1982). Since many of
he important human papillomavirus infections affect the
nogenital mucosa, studies of viral biology in a mucosal
odel are important. One such model, palatine infection
y bovine papillomavirus type 4 (BPV-4) in calves, has
een used to study temporal and spatial expression of
iral proteins (Anderson et al., 1997). However, RNA in
situ hybridisation was not undertaken, and viral DNA
proved undetectable in basal or suprabasal keratino-
cytes with the technique used.
Canine oral papillomavirus (COPV), reviewed in Ni-
cholls and Stanley (1999), has been used for the devel-
opment of vaccines both historically (Chambers et al.,
1960) and more recently (Bell et al., 1994; Ghim et al.,
1995). Furthermore, COPV has been used to establish
the efficacy of DNA vaccines (Stanley et al., 2001). Some
COPV infections have similarities to HPV-associated re-
current laryngeal papillomatosis (Nicholls et al., 1999).
Since the dog is a useful animal model of mucosal
papillomavirus infections, it provides an important oppor-
tunity for studying the viral life cycle in vivo, allowing
early biopsies to be taken in a controlled manner at
accurately defined intervals after infection. In the COPV
model, we have used a chronological series of biopsies,
taken from infection through to regression, to analyse the
viral life cycle by means of histopathology, in situ hybri-
disation, and immunohistochemistry. We were able to
detect viral RNA, DNA, and protein during the early
stages of infection within the basal and suprabasal
(lower stratum spinosum) keratinocytes of preclinical le-
sions, providing insight into the likely location of the
target cell. Double-labeling of viral E4 and L1 proteins
revealed both temporal and spatial differences in expres-
sion in distinction to the findings of previous reports
using material from human warts (Brown et al., 1994,
1995). Additionally, double-labeling of viral DNA and viral
E4 protein showed a strong colocalisation at the cellular
level even at early time points, supporting the hypothesis
that, in addition to its suggested role late in the viral life
cycle (Doorbar, 1996; Doorbar et al., 1991), E4 may play a
role in the earlier stages of infection, perhaps in viral
DNA replication (Doorbar et al., 1997). The detection of
abundant viral DNA and protein in basal keratinocytes of
COPV lesions highlights the differences in viral biology
between viral types and indicates that generalizations
about the biology of different papillomavirus types
should be made with caution.
RESULTS
Morphological changes during wart development and
regression
Haematoxylin and eosin stained sections from tissues
taken 1–4 weeks p.i. were morphologically similar to
pre-infection controls. At Week 5, an increased meanmitotic rate (Fig. 1) was associated with expansion of the
stratum spinosum (Fig. 3a). After further epithelial thick-
ening, filiform papillae appeared with koilocytes in spi-
nosum and granulosum strata by Week 8 (Fig. 4e). Fro-
zen sections revealed a thickened stratum corneum
without nuclear retention. In places, a focal infiltrate of
inflammatory cells obscured the dermo-epidermal junc-
tion. By Week 8, mature papillomas developed multiple
projecting papillae rising 5–10 mm above the surround-
ing mucosal surface. Significant numbers of lymphocytes
were present intraepithelially and around the interface of
the epithelium and lamina propria, in some places ob-
scuring the basement membrane zone. Occasional apo-
ptotic keratinocytes were seen in the lower layers. By
Week 9, the infiltration of inflammatory cells, mostly lym-
phocytes, was more marked and the papilloma had re-
duced in size. There was a prominent influx of neutro-
phils with intercellular oedema. As the papillomas re-
solved during Week 10, the epithelium reformed,
although there were still patchy foci of intraepithelial and
subepithelial inflammation. By Week 11, the oral mucosa
appeared morphologically normal and the cycle of pap-
illoma progression and regression was complete.
Analysis of viral location and replication by DNA in
situ hybridisation
To identify sites of viral DNA replication during wart
formation and regression, the chronological series of
biopsies was examined by DNA in situ hybridisation
using a digoxigenin-labeled COPV genomic probe. No
DNA was detectable in pre-infection sections or in sec-
tions from 1 to 3 weeks p.i. Viral DNA was first detected
at 4 weeks, in only some of the sections examined and
was restricted to scattered foci of positive nuclei in the
FIG. 1. Mean (1SD) mitotic rate per 325 field during COPV lesion
progression and regression. The increase in mean mitotic rate at Week
5 coincided with the first appearance of macroscopic lesions and with
the detection in situ of abundant viral DNA. Signs of wart regression
ere seen from Week 8.basal layer or immediately above it. The tight clusters of
positive cells suggested a clonal origin. In places, these
intense
84 NICHOLLS ET AL.early foci were found at the lower tips of the epithelial
projections or rete ridges (Fig. 2b). Some sections re-
vealed early foci in the saddle region between the rete
ridges (Fig. 2c). Occasional foci of positive nuclei in a
suprabasal position, apparently unconnected to the
basal layer, were tracked back to the basal layer or deep
FIG. 2. Early events in COPV infection—Weeks 4 and 5. Viral activity
canine oral mucosa (a), and viral DNA was found in multiple tight cluste
(c). Probes for E4 RNA also gave the first signal in rete ridges at Week
probe (e) had a similar pattern and intensity to that of the E4 probe. Th
present also. E4 protein was present in a faint pattern with occasional
membrane. [(a–e) and (g) 3200; (f) 3100].rete ridges by in situ hybridisation of serial sections.
From Week 5 to Week 6, more positive cells appearedwithin the basal and suprabasal layers until nearly every
cell within the basal layer and layers immediately above
was positive (Fig. 3b). The foci where viral DNA was
detectable correlated with focal increases in epithelial
thickness and mitotic rate, demonstrating a link between
viral replication and keratinocyte division.
undetectable until Week 4. At Week 4, the histology resembled normal
g from rete ridges (b), sometimes extending along the shoulder region
extended along the intervening shoulder region by Week 5 (d). The E2
obe found similar basal foci (f), although background signal dots were
staining in basal and suprabasal cells (g). Arrowheads indicate basalproved
rs arisin
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e E7 prAs the papilloma matured through Weeks 7 and 8, only
certain superficial keratinocytes appeared to permit the
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was in contrast to the situation in the lower layers in
which almost every keratinocyte was positive for viral
DNA. It was these superficial, strongly positive keratin-
ocytes, apparently supporting high level genome ampli-
fication, which had vacuolated cytoplasm typical of koilo-
FIG. 2
FIG. 3. Early events in COPV infection—Weeks 5 and 6. By Week five
any mitoses and were positive for viral DNA in nearly all basal cells
bserved with the E4 (c), E2 (d), and E7 (e) RNA probes. In some are
uprabasal keratinocytes (f), and this signal colocalised on a cell-to-c
abeled for both E4 protein and viral DNA (g). Arrowheads indicate bacytes. As the papillomas regressed during Week 9, less
DNA was detected in the lower layers of the epitheliumdespite remaining prominent more superficially, until no
signal remained by Week 10.
Detection of transcripts from the E2/E4 region
Probes to the E2 open reading frame were made
inued
were foci of epithelial thickening (a). These thickened areas contained
er with a large fraction of suprabasal cells (b). A similar pattern was
E4 antibody detected a faint but distinct signal in foci of basal and
is with cells positive for viral DNA, as demonstrated in serial section
mbrane. [(a–e) 3100; (f and g) 3200].—Cont
, there
, togeth
as, thecomplementary to regions spanning nucleotides 2694–
3058 (E2 probe A) and 3460–3710 (E2 probe B). These
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within a different reading frame. E2 probe A did not,
FIG. 3
FIG. 4. Late events in COPV infection—Weeks 7 and 8. E2 (a) and E
hey were detecting the same transcripts. Late transcripts were detec
eek 8, with serial sections for L1 (c) and L2 (d) showing an identical
e) with koilocytes in the upper epithelial layers (inset). Sporadic cells
ogether with vacuolated cytoplasm typical of koilocytes. Probes for E4
f superficial cells, whereas L1 (j) was seen only superficially. L1 prote
l). Double labelling confirms that L1 protein is confined to a superficial
resent in the same subset of cells, as revealed by double labelling,
embrane. [(a and b) 340; (c–k and m) 3100; (l, n, and o) 3200].however, allow reliable detection of transcripts and was
not extensively used. By contrast, E2 probe B detectedabundant transcripts within both experimental and clin-
ical lesions. In the mature clinical lesions, signal was
inued
NA probes continued to show similar patterns at Week 7, suggesting
ccasional superficial keratinocytes by Week 7 but were abundant by
. Filiform papillae, typical of mature papillomas, developed by Week 8
more superficial epithelium had very strong signals for viral DNA (f),
(h), and E7 (i) showed transcription in both basal cells and a subset
superficial only (k), in distinction to the expression of E4 in all layers
of E4-expressing cells (m). E4 protein and high-copy COPV DNA were
lower (n) and upper (o) epithelial layers. Arrowheads indicate basal—Cont
4 (b) R
ted in o
pattern
in the
(g), E2
in was
subsetlocated mostly within the basal layer but was found also
within the other lower epithelial layers and extended
—Cont
87CANINE ORAL PAPILLOMAVIRUS LIFE CYCLEsuperficially within a subset of cells. In the experimental
series, signal was abundant basally through Weeks 5–8
(Figs. 2e, 3d, and 4h) and declined as the wart regressed.
Signal was present in a subset of suprabasal and more
superficial layers in the maturing wart (Fig. 4h) and was
absent by Week 10. The E4 riboprobe was complemen-
tary to the region between nucleotides 3193 and 3429.
The probe detected abundant transcripts within the ma-
ture clinical lesions. The signal was abundant in basal
FIG. 4layer keratinocytes, in rete ridges, and in sporadic cells
throughout the lower half of the epidermis but on occa-sions was confined to the basal layer. Within the exper-
imental series, transcripts from the E4 ORF were first
detected at 4 weeks p.i. in the basal and immediately
suprabasal layers (Fig. 2d). The transcripts were found in
abundance from Week 5 and throughout wart progres-
sion (Figs. 3c and 4g), beginning to fade from Week 9 as
the warts regressed, and disappearing by Week 10. E2
probe B and the E4 probe are both predicted to detect all
early transcripts as well as transcripts originating from
inuedthe differentiation dependent promoter, which in other
papillomavirus types is situated upstream of E1. The
—Cont
88 NICHOLLS ET AL.strength of the signal and the similarities between the
staining patterns of the two probes suggests both are
detecting the spliced E1 E4 message, which is ex-
pressed at high level by other papillomavirus types.
Detection of transcripts from the E6/E7 region
The E7 probe was complementary to a region be-
tween nucleotides 575 and 740. The probe detected
abundant transcripts in mature clinical papillomas.
FIG. 4Signal was present in the basal layer and a subset of
more superficial keratinocytes. In the experimentalseries, signal was first detected at 4 weeks p.i. in only
the lowest layers of epithelium. By Week 5, the signal
was more abundant especially in the rete ridges (Fig.
2f). As the lesions progressed, some keratinocytes in
more superficial layers contained abundant tran-
scripts (Figs. 3e and 4i). The signal was present in
numerous superficial cells by Week 8, declining there-
after, until absent by Week 10. The E6 probe, comple-
mentary to the region between nucleotides 150 and
inued492, did not reliably detect transcripts and was not
extensively studied.
89CANINE ORAL PAPILLOMAVIRUS LIFE CYCLEDetection of transcripts from the L1/L2 region
The L1 probe was complementary to a region between
nucleotides 7397 and 7755. Naturally occurring canine
oral papillomas contained abundant transcripts from the
L1 ORF in only the stratum granulosum or uppermost
stratum spinosum. No signal was ever detected below
this level. In the experimental series, L1 transcripts were
first detected in small amounts at 7 weeks p.i. in the
superficial keratinocytes. The transcripts were abundant
by Week 8 (Figs. 4c and 4j) and still present at Week 9.
No transcripts were present at Weeks 10 and 11. Tran-
scripts were present in both cytoplasmic and nuclear
locations.
The L2 probe spanned a region from nucleotides 5771
to 6110. Transcripts were present in the superficial ker-
atinocytes of mature clinical lesions but not in keratino-
cytes of the lower epithelial layers. In the experimental
series, signals were not detected until week seven, as
for the L1 transcripts. Transcripts were found in superfi-
cial keratinocytes only, and became more abundant by
Week 8 (Fig. 4d) with a pattern identical to that of L1.
Some signal remained at Week 9, but none was detected
at Weeks 10 or 11. Nuclear signal was occasionally seen
with the sense control probe, sometimes concentrated
over the nucleoli (data not shown).
Expression of the L1 capsid protein during the time
course of infection
Although RNA in situ hybridisation provides some in-
sight into the pattern of viral gene expression during wart
formation, papillomavirus mRNAs have complex splicing
patterns, and the detection of RNA from a viral open
reading frame does not necessarily indicate synthesis of
viral proteins. Polycistronic transcripts are not necessar-
ily expressed throughout their length, and in other pap-
illomavirus types, posttranscriptional mechanisms pre-
venting protein expression have been reported. To de-
termine the expression patterns of viral proteins during
wart formation and regression, immunohistochemistry
was undertaken using antibodies specific to the viral
proteins—E4 and L1.
The presence of L1 protein correlated well with detec-
tion of L1 transcripts except that the L1 gene products
were restricted to the nucleus in the stratum granulosum,
becoming cytoplasmic only in the stratum corneum
where nuclear disintegration is likely. No L1 protein was
seen in pre-infection controls or in samples from Weeks
1 to 6 inclusive. An occasional positive nucleus was
seen in the stratum granulosum at Week 7. By Week 8,
there were numerous positive keratinocyte nuclei in the
stratum granulosum with the signal extending into the
stratum corneum (Fig. 4k). Only an occasional positive
cell was found during early regression at Week 9, and no
virus capsid was detectable by Weeks 10 and 11.Expression of the viral E4 protein during the time
course of infection
E4 is abundantly expressed in lesions caused by sev-
eral human papillomavirus types. The role of E4 in the
virus life cycle is unclear, and its expression pattern
during wart formation and regression has not been es-
tablished. To generate antisera, immunisations were car-
ried out using a glutathione S transferase COPV E4
fusion protein expressed in bacteria. Antibody specificity
was confirmed by Western blotting using maltose bind-
ing protein (MBP) fusions containing the E4 gene prod-
ucts from COPV, ROPV, or HPV 11. Reactivity was appar-
ent only with the COPV E4 fusion (data not shown).
In mature clinical COPV papillomas, immunostaining
revealed a predominantly cytoplasmic signal for E4 in
sporadic cells of the basal layer and above (Fig. 5). The
E4 staining pattern was very heterogeneous. In some
cells, the protein existed as cytoplasmic inclusions while
in others the staining was diffuse and extended through
the nucleus. Where nuclear staining was apparent, the
E4 protein was concentrated around the periphery of the
nucleoli (Figs. 5a and 5g). In the experimental series, E4
was first detected at Week 4—and until Week 6, staining
was apparent in the lower epithelial layers at levels
close to the limits of detection (Figs. 2g, 3f, and 3g). By
Week six, sporadic cells showed high level E4 expres-
sion (as apparent from intensity of immunostaining), with
levels of expression increasing from Week 7 to Week 8
(Fig. 4l). In the experimental lesions, E4 could be de-
tected both in the nucleoli as well as the cytoplasm at
Weeks 7 and 8 (Fig. 6). This distribution, which was not
apparent in established clinical material was confirmed
by confocal microscopy and phase contrast imaging (Fig.
6). In both the experimental and clinical material, E4
expression was first detected in the basal cells. E4
protein remained at Weeks 8 and 9 and was apparent at
the advanced stages of regression. No E4 was detect-
able at Weeks 10 or 11.
Correlation of viral protein expression with genome
amplification by double staining
Some reports have indicated that the expression of E4
colocalises exactly with that of L1 (Brown et al., 1994),
whereas more recent work indicates that L1 expression
is accompanied by expression of E4 but that the con-
verse is not true with E4 appearing additionally in lower
epithelial layers (Doorbar et al., 1997). COPV lesions
were first stained for L1 and developed to give a dark-
purple reaction product. After washing, the same sec-
tions were stained for E4 and developed to give a brown
reaction product. Although E4 was expressed in the
absence of L1 in the lower epithelial layers, L1 expres-
sion occurred only in E4-positive cells in the superficial
layers (Fig. 4m). These correlations were seen in estab-
lished clinical biopsies and those from Week 7 in the
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90 NICHOLLS ET AL.experimental time course. To determine whether viral
DNA replication and E4 expression coincided during the
course of COPV infection, immunolocalisation was car-
ried out on sections previously hybridised to detect viral
DNA. The sensitivity of antibody staining was increased
FIG. 5. E4 localisation in mature clinical papillomas. E4 staining was p
granular appearance was evident in the cytoplasm of some cells (arr
ometimes concentrated around the periphery of the nucleoli (arrow
ounterstain was used to visualize the nucleus (red; d and h), E4 was la
blue; b and f). [(a–h) 3200].by the in situ hybridisation step, while the nuclear loca-
ion of viral DNA and the predominantly cytoplasmic
W
4ocation of E4 enabled double labeling to be interpreted
learly. Expression of E4 correlated closely on a cell-to-
ell basis with viral DNA replication at all time points,
nd both occurred in the basal and more superficial cell
ayers. These relationships were demonstrated from
inantly cytoplasmic but some nuclear staining was also apparent (a–d).
tre) while in others, E4 was more diffuse (arrow bottom right). E4 was
–g). Arrowheads indicate basal membrane (e–h). Propidium iodide
with FITC (green; c and g), and COPV DNA was labeled with coumarinredom
ow cen
ed) (eeek 4 onwards, although at early time points (Weeks
–6), the level of E4 expression was close to the sensi-
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91CANINE ORAL PAPILLOMAVIRUS LIFE CYCLEFIG. 6. E4 localisation in experimental papillomas. E4 was apparent in the cytoplasm, nuclei, and nucleoli (arrowed in a) at Weeks 7 and 8 (a–d).
he nucleolar distribution was confirmed by confocal immunofluorescence microscopy and phase contrast imaging (e–g). Arrows and asterisks
ndicate the positions of the nucleoli (e–g). Asterisks identify nucleoli that did not stain with antibodies to E4. Arrows indicate nuclei that contain E4
rotein. E4 antibody was labeled with FITC (green; a, c, e, and f) and COPV DNA was labeled with coumarin (blue; e and f). Propidium iodide
ounterstain was used to visualize the nucleus (red; b and d). [(a and b) 3100; (c and d) 3400; (e–g) 3200].
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time points all of the E4-positive cells in the parabasal
layers were found to be supporting viral DNA replication.
In clinical lesions, and between Weeks 7 and 8 in the
experimental warts, sporadic cells could be detected
that had higher levels of E4 and higher levels of DNA
replication (Figs. 4n, 4o, 5, and 6). As previously reported,
high-level expression of E4 coincided closely with veg-
etative viral DNA replication, although occasional cells
were apparent that were positive for DNA replication yet
negative for E4 and vice versa.
L1 expression did not colocalise with DNA amplifica-
tion in the lower half of the epithelium since L1 protein
was undetectable despite the presence of abundant viral
DNA. Furthermore, viral genome amplification was de-
tectable from Week 4, whereas L1 was not seen until
Week 7. In the mature lesions, L1 was present only
superficially (Fig. 4k), whereas DNA was detectable in all
layers (Fig. 4f). L1 colocalised with DNA in the upper
epithelium as the L1 signal overlaid the darker DNA
signal when enzymatic detection was carried out (data
not shown).
DISCUSSION
The delay before COPV lesion appearance is well
documented (Bell et al., 1994; Chambers and Evans,
1959; Konishi et al., 1972), and a delay of 4 weeks before
COPV DNA is detectable is similar to that described in
other models (Sterling et al., 1990; Stoler et al., 1990).
COPV infection by injection, rather than scarification,
prolongs this lag phase (our unpublished data) presum-
ably because the reduced epithelial trauma provides
little stimulus for epithelial repair and stem cell division.
Stimulation of viral DNA replication following epithelial
trauma has been well documented (Amella et al., 1994;
Campo et al., 1994; Whiteley, 1956, 1957). In haired skin,
a likely site of stem cells is the follicular bulge region
(Cotsarelis et al., 1990; Michel et al., 1996), where early
RPV gene expression was found (Schmitt et al., 1996)
s well as interfollicular epidermis (Miller et al., 1993). In
non-haired epithelia, stem cells are thought to be located
at the tips of rete ridges (Hume and Potten, 1983; Lavker
and Sun, 1982; Michel et al., 1996). Early COPV lesions
showed a distribution of viral DNA and RNA consistent
with infection of a stem cell at this site, and the apparent
subsequent tracking up the side of the ridge toward the
shoulder region resembles proposed trafficking from the
stem cell through transient amplifying compartments and
into postmitotic epithelium (Lavker and Sun, 1983). The
data presented here are compatible with the idea that
the virus infects a basal keratinocyte (Evander et al.,
1997; McMillan et al., 1999), most likely a slowly cycling
keratinocyte stem cell (Stanley, 1994).Reports using other papillomaviruses found viral DNA
in only the more superficial epithelial layers. For in-stance, high-copy numbers of BPV-4 DNA were seen in
only the spinous and squamous layers of papilloma
fronds (Anderson et al., 1997), and in recent studies of
HPV-1 biopsies, no viral DNA or RNA could be detected
in basal keratinocytes (Egawa et al., 2000). HPV DNA
was detected in the basal layer in CIN 3 lesions, but in a
pattern suggesting viral integration (Cooper et al., 1991)
rather than as a normal part of the virus life cycle. A
degree of HPV DNA amplification in basal cells in vitro
has been reported as challenging the concept that viral
genome amplification is linked to differentiation (Ozbun
and Meyers, 1998). The basal layer, however, is not made
up from a single undifferentiated cell type but includes
stem cells, transient amplifying cells, and postmitotic
differentiating cells expressing keratin 10 (normally a
spinous layer keratin) (Li et al., 1998). Also, an occasional
report of filaggrin expression in the basal layer, rather
than granular and cornified layers (Mayer and Meyers,
1998), suggests that cellular differentiation of some in
vitro systems may differ from that in vivo.
In this study, COPV DNA was readily detected in basal
keratinocytes, indicating a substantial level of DNA rep-
lication at this level. Although protease K digestion and
the degree of stringency during washing were critical in
detecting DNA in basal keratinocytes, the repeated fail-
ure, in numerous studies, to detect high-level DNA rep-
lication in basal epithelium of other papillomavirus infec-
tions suggests that not all papillomavirus types produce
such abundant DNA. Interestingly, COPV is related to the
cutaneous HPV types 1 and 63 (Delius et al., 1994) and
abundant low-level, although not basal, DNA replication
has been described in HPV-1 (Doorbar et al., 1997;
Egawa et al., 2000). An important feature of the COPV
genome is the lack of an E5 open reading frame (Delius
et al., 1994), the functions of which may be taken over by
other COPV gene products. This may underlie the tran-
scriptional differences between COPV and other infec-
tions. Furthermore, the COPV genome contains a unique
noncoding region of uncertain function between its E2
and L2 open reading frames (Delius et al., 1994). Such
genomic differences hinder generalizations about papil-
lomavirus biology. The unusually high level of basal DNA
replication and transcriptional activity seen in COPV in-
fections may be responsible for the typically early regres-
sion of the resulting papillomas, perhaps due to early
immunological recognition of viral proteins by the host.
The initial multifocal clustering of COPV DNA-positive
cells is consistent with their origin from keratinocyte
stem cells, which make up only a few percent of cells in
the basal layer. Nearly every cell at the basal and several
suprabasal strata of the epidermis appeared permissive
for viral replication to a moderately high copy number.
Why only a certain fraction of more superficial epithelial
cells take DNA replication through to an even higher
copy number is not clear, but this presumably reflects
either a uniquely permissive environment within these
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fluences with a bistable outcome. These koilocytes were
the cells in which virus was assembled as revealed by
double-labeling for viral DNA and L1 capsid protein.
Polyclonal antibodies against GST fusion proteins of full-
length COPV E2 and E7 also revealed staining in the
nuclei of koilocytes of mature papillomas (our unpub-
lished observations). The same patchy distribution of
cells with high DNA copy number has been seen in vitro
(Ozbun and Meyers, 1998). A greater understanding of
the factors controlling this permissive environment might
provide insight into possible avenues for therapeutic
intervention.
The disappearance of viral DNA noted in lower layers
of regressing warts, seen also in BPV-4 lesions (Ander-
son et al., 1997), could arise if the putative stem cell viral
reservoirs were destroyed during immune regression or
if viral replication is shut down by cytokines either per-
manently or to be reactivated after a period of latency, a
theory supported by PCR-based detection of COPV DNA
in mucosa from sites of regressed papillomas (our un-
published data).
Although thought to have late functions, the pattern of
E4 transcription and protein expression seen in this
study appeared more typical of a papillomavirus early
gene. The transcription pattern had an early onset and
was one of the earliest detectable events during the time
course of COPV infection. E4 transcripts (E1 E4 mRNAs)
are the most abundant mRNA species seen in HPV-11-
infected human foreskin xenografts and are located pre-
dominantly in the midepithelial and more differentiated
layers (Stoler et al., 1990) as found here at late time
points. Identification of the E4 protein at early time points
indicates that at least some of this message serves as a
template for the synthesis of E4 protein. A similar distri-
bution was apparent for E7 mRNAs, which were found in
basal keratinocytes as well as in a subset of cells within
the stratum spinosum and stratum granulosum. This is
similar to the pattern previously reported in HPV-11-
infected foreskin xenografts where E6-E7 transcripts
were detectable from Week 6, although parabasally at
first and then in the middle epithelial layers (Stoler et al.,
1990). Similarly, in CRPV-induced lesions, E6-E7 tran-
scripts are detected in the hair follicles at Day 11
(Schmitt et al., 1996) and become stronger in the basal
ayers by Day 45. E7 mRNAs are detected throughout the
pithelium in established lesions caused by both HPV-16
nd CRPV (Higgins et al., 1991, 1992; Zeltner et al., 1994).
Transcription from late regions was markedly different
from that of the other ORFs. A similar pattern of late gene
transcription has been seen in HPV-11- infected foreskin
xenografts (Stoler et al., 1990). The intensity of staining
suggested that the L1 transcripts are more abundant
than those of L2 as in HPV-31 (Ozbun and Meyers, 1997).
L1 protein is expressed at higher levels than L2 in cuta-
neous human warts (Doorbar and Gallimore, 1987). In theCOPV lesions, cells containing L2/L1 transcripts and L1
protein had swollen pale cytoplasm as reported with
BPV-4 (Anderson et al., 1997; Gaukroger et al., 1989).
These koilocytic cells additionally contained high levels
of viral DNA. Despite the abundant viral DNA and E4 in
the lower epithelium, no L1 was detected in the lower
half of the epidermis. This is in contrast to HPV-1 lesions,
in which L1 transcripts and protein were detected in
suprabasal layers (Egawa et al., 2000).
RNA in situ hybridisation showed clearly different tran-
scription patterns for COPV L1 and E4 open reading
frames. This is not consistent with earlier reports that L1
and E4 proteins colocalise at the cellular level (Brown et
al., 1994, 1995). Interestingly, in the study of Brown et al.,
the E4 protein did not precede the L1 protein, despite the
presence of E4 transcripts in lower layers than L1 tran-
scripts (Brown et al., 1995). In COPV lesions, however,
good correlation between E4 mRNA and E4 protein was
found. E4 expression preceded L1 expression, although
L1 was always accompanied by E4 expression in the
same cell.
Although E4 has been reported as being nuclear in
location (Palefsky et al., 1991), recent work with HPV-16
lesions showed that E4 expression, although variable in
amount, correlated exactly with DNA replication but not
L1 expression and was cytoplasmic (Doorbar et al.,
1997). The cytoplasmic location of E4 within cells of the
granulosum and upper spinosum strata was confirmed
by immunoelectron microscopy of athymic mouse
HPV-16 xenografts (Sterling et al., 1993) with viral capsids
detected microscopically and by immunogold staining
(L1) in the nucleoplasm of the same cells. The associa-
tion of E4 with cytoskeletal elements (keratin tonofibrils)
was demonstrated in the same report. L1 expression is
preceded by E4 expression but colocalises at the cellular
level with E4 in the superficial layers (Doorbar et al.,
1997), a finding mirrored in the COPV lesions described
in this study. This dissociation of L1 and E4 expression is
demonstrated also by the lack of effect of protein kinase
C activators on E4 expression in raft cultures, whereas
L1 expression is upregulated (Meyers et al., 1992). E4 of
HPV-31b was detected in rare cells in monolayer culture,
but its expression was upregulated upon differentiation
of the same cells in raft culture (Pray and Laimins, 1995),
with E4 protein located mostly in spinosum and granu-
losum strata, occasionally extending into the stratum
corneum. Whilst occasional (,1%) basal cells were de-
scribed as expressing E4, none was shown in the report.
In the HPV-31b study, as in this study, most L1-positive
cells also expressed E4, but the converse was not true.
The finding that E4 is expressed early on in the virus
life cycle and in basal cells and is dissociated from
expression of L1 suggests that E4 is an early protein in
COPV. These findings do not support the theory that E4 is
a late protein with a role in releasing virus from cells
(Doorbar, 1996; Doorbar et al., 1991), although it may be
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94 NICHOLLS ET AL.multifunctional. A role for E4 in DNA replication has been
suggested (Doorbar et al., 1997), and a close correlation
as found between the detection of high copy number
iral DNA and COPV E4 protein both temporarily and
patially. A similar correlation has previously been re-
orted in other species. In mucosal lesions caused by
PV-16 and cutaneous lesions caused by HPV-1 and
PV-63, the onset of genome amplification coincides
losely with E4 expression (Doorbar et al., 1997), while in
lesions caused by BPV-4 a similar correlation has been
reported (Anderson et al., 1997). Colocalisation of E4 with
genome amplification has also been demonstrated in
HPV-infected keratinocytes grown in methylcellulose
suspension (Ruesch et al., 1998). These findings suggest
a role of E4 in vegetative viral DNA replication, perhaps
by sequestering cellular factors that inhibit episomal
replication (Breitburd et al., 1987), maybe by tethering
them to the cytoskeleton. The two proposed functions of
E4, cytoskeletal interactions to assist viral egress (a late
function) and involvement in DNA replication, might not
therefore be mutually exclusive. Colocalisation does not
prove causality, and it has been suggested that vegeta-
tive viral DNA replication may permit expression of E4,
L1, and L2 by titrating out cellular factors normally inhib-
iting the late promoter (Frattini et al., 1996). Although the
E4 protein of HPV-16 can localise to the nucleoli when
the LLXLL cytoplasmic anchor motif is removed (Doorbar
et al., 2000), the functional significance of our demon-
stration of nucleolar COPV E4 at certain points in the life
cycle is not clear.
COPV is a mucosal papillomavirus, but is more closely
related to the cutaneous HPV types 1 and 63 at the
nucleotide sequence level, with minimal sequence sim-
ilarity to mucosatropic HPVs, including the oral HPV
types 13 and 32 (Delius et al., 1994). The abundant viral
replication and expression of E4 low in the epidermis
and the high level of virion production in COPV are
similar to findings in the related human papillomavi-
ruses, HPV-1 and HPV-63, suggesting that the biological
properties of papillomaviruses may not correlate well
with their preferred target tissues and that the often-cited
distinction between mucosatropic and cutaneous PV
types is somewhat arbitrary. Even the closely related
HPV-1 and HPV-63 cutaneous HPVs have different E4
staining characteristics with coalescing intracytoplasmic
inclusions in the former and fibrous/granular distribution
in the latter (Doorbar et al., 1997). It seems that there may
be no one “typical” pattern of papillomavirus infection
since the different papillomavirus types appear to differ
from one another quite markedly with respect to onset of
vegetative DNA replication, timing and pattern of E4
expression, and amount of infectious virus produced. It is
clearly difficult to generalize about the virus life cycle
across so many widely differing viral types, and an un-
derstanding of these differences in viral biology could
u
pprove important in attempts to develop therapeutic inter-
ventions for papillomavirus-related disease.
MATERIALS AND METHODS
Experimental infection
Two female, 10- to 12-week beagles were housed
together in purpose-built, climate-controlled accommo-
dation, in an air space separate from other dogs in the
building, with a virucidal footbath at the common en-
trance and exit. All staff changed their protective clothing
(gown, gloves, boots) on entering the controlled area.
Under general anaesthesia, the mucosa of the upper lip
was lightly scarified over an area ;5 3 5 mm, using the
tip of a scalpel blade, until a light ooze of blood occurred.
Neat COPV wart suspension (Bell et al., 1994) (a kind gift
from A. B. Jenson, Georgetown University, Washington,
D. C.) was applied (10 ml) to each site by pipette and
llowed to absorb for a few minutes. The site of chal-
enge was marked by Indian ink tattoo points in a triangle
entred on the site. Twelve sites were infected in each
og. Control oral mucosal biopsies were taken prior to
hallenge.
Under general anaesthesia, further weekly biopsies of
he oral mucosa were taken using a 6-mm punch biopsy
r scalpel followed by suturing as appropriate. Where
ross lesions had not yet developed, tissue was taken
rom the tattoo-marked sites. The biopsies were fixed in
0% neutral buffered Formalin then processed after 4–8 h
o paraffin wax for routine (5–7 mm) sectioning. At the
nd of the experiment all animals were re-homed.
mmunohistochemistry
Immunohistochemistry of Formalin-fixed, paraffin-em-
edded sections was performed using a secondary an-
ibody conjugated to either FITC or Texas red (Amer-
ham, UK) or using an avidin-biotin complex (Vectastain
BC, Vector Laboratories) as previously described (Ni-
holls et al., 1999). Positive control sections were canine
ral papillomas with virions confirmed by transmission
lectron microscopy. Pre-infection biopsies acted as
egative controls. Omission of primary or secondary
ntibody provided further negative controls.
For the detection of L1, the primary antibody was
AMVIR-1 mouse IgG2a monoclonal (McLean et al.,
990) diluted 1:1000 in PBS, with biotinylated polyclonal
oat anti-mouse IgG2a (Amersham, UK), diluted 1:400 in
BS, as secondary antibody. For the detection of E4, the
rimary antibody was polyclonal rabbit anti-COPV E4-
ST fusion protein diluted 1:2000 in PBS, with biotinyl-
ted polyclonal goat anti-rabbit (DAKO E432), diluted
:400 in PBS, as secondary antibody. FITC or Texas-red-
onjugated antibodies (Amersham N1031, N2031) were
sed at a dilution of 1:50. The polyclonal E7 antibody was
repared by immunisation of a rabbit with a full-length
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95CANINE ORAL PAPILLOMAVIRUS LIFE CYCLECOPV-E7 GST fusion protein expressed and purified from
Escherichia coli. The E7 antibody was pre-absorbed
against GST protein and used at 1:600 in PBS containing
10% normal goat serum with the same secondary anti-
bodies as for E4 immunohistochemistry.
Double-labeling immunohistochemistry for L1 and E4
Sections were treated as for L1 immunostaining, ex-
cept an alkaline phosphatase tertiary complex (Vec-
tastain ABC, Vector Laboratories) was used for colour
development with 5-bromo-4-chloro-3-indolyl phosphate
(BCIP) and nitroblue tetrazolium chloride (NBT) as the
substrate. The reaction was stopped by immersion in TE
buffer for 20 min before the second label was applied.
For the second label, sections were washed in 0.2%
Triton X-100 in PBS for 5 min, followed by washing in PBS
(3 3 3 min). The second primary antibody (for E4) was
applied overnight at 4°C. The sections were washed as
before, then the secondary antibody (peroxidase-conju-
gated swine anti-rabbit (DAKO P217) diluted 1:400 in
PBS) was applied for 30 min at room temperature. After
further washing, the label was developed with 0.06% 3,39
iaminobenzidine tetrahydrochloride (DAB), 0.01% hydro-
en peroxide in 0.1M Tris (BDH), pH 7.5. The reaction was
topped by washing in water, followed by counterstain-
ng (Carazzi’s haematoxylin, 45 s).
NA–DNA in situ hybridisation
A digoxigenin-labeled, nick-translated (Boehringer
Mannheim, Mannheim, Germany) genomic COPV DNA
probe was used for DNA–DNA in situ hybridisation as
escribed previously (Nicholls et al., 1999). Briefly, after
ewaxing and rehydration, sections were digested with
roteinase K (50 mg/ml for 15 min at 37°C), washed in
BS, dehydrated, and air-dried. The DNA probe in hybri-
isation buffer was applied, and the coverslipped slides
ere denatured (6 min at 95°C), quenched on ice, and
ybridised overnight at 37°C. Stringency washing at
oom temperature in 0.53 SSC (3 3 5 min), at 55°C in
0% formamide/13 SSC for 10 min, and at 55°C in 0.53
SC (3 3 5 min) was followed by alkaline phosphatase
evelopment overnight with BCIP/NBT substrate. Alter-
atively, in situ hybridization was carried out using a
yramide signal amplification procedure (NEN Life Sci-
nce Products). The hybridised probe was detected us-
ng anti-Dig-HRP and peroxidase activity was detected
ith coumarin tyramide.
To control for background associated with the different
etection systems, such as nonspecific binding of the anti-
igoxigenin antibody, endogenous alkaline phophatase, or
onspecific precipitation of the chromogen, the COPV DNA
robe was omitted. To control for nonspecific binding of
robe DNA by the tissue, an irrelevant DNA probe (HPV-16
r ROPV DNA) was substituted for the COPV probe. To
ontrol for other false-positive signals and to establish
m
uackground signal levels, pre-infection biopsies (Week 0)
ere included. As positive controls, sections known to be
ositive for COPV virions by immunohistochemistry and
lectron microscopy were included in each run. Further
cceptance criteria included the restriction of positive sig-
als to the epithelium, more specifically to the keratinocyte
ucleus, and an absence of signal in adjacent normal
issue. Control sections, not denatured by heat, were used
o ensure that double-stranded viral DNA, rather than viral
NA, was being detected. An additional control to rule out
ormation of DNA–RNA hybrids was to digest the section
ith RNaseA prior to hybridisation, although the manufac-
urer indicates that such a step is not typically required.
ouble-labeling of DNA and either L1 or E4 protein
Sections were processed for detection of viral DNA as
escribed above. After stopping the reaction in TE buffer
or 10 min, the sections were washed in 0.2% Triton X-100
n PBS for 5 min before further washing in PBS (3 3 3
in). The L1 or E4 primary antibody was applied over-
ight at 4°C, washed in PBS (3 3 3 min), and the
ppropriate secondary antibody was applied for 30 min
t room temperature. After washing in PBS, peroxidase-
onjugated avidin-biotin complex (Vectastain Elite, Vec-
or Laboratories), or a secondary antibody conjugated to
ITC or Texas red, was applied for 30 min at room
emperature, and the sections were washed again be-
ore visualisation by fluorescent microscopy or develop-
ent with DAB (peroxidase conjugates). The reaction
as stopped by washing in water, followed by counter-
taining (Carazzi’s haematoxylin, 45 s).
valuation of mitotic index
Mitotic figures were counted from haematoxylin and
osin stained sections, using a light microscope with
25 objective. An eyepiece graticule was used to define
ach field within which mitoses were counted. The mean
ount per field was established by counting all epithelial
ields within the section and repeating the count on a
econd section from the same time point.
eneration of RNA probes
Segments were amplified by PCR from the reference
lasmid (COPV genome in pBR322). The locations of the
robes relative to the COPV open reading frames is
llustrated in Fig. 7. Probe length was restricted to be-
ween 200 and 500 bp to ensure good tissue penetration
hilst maintaining high specificity. The primers added
coRI and BamHI as flanking sequences, enabling di-
ectional cloning into the vector pGEM3Z (Promega).
fter transformation of E. coli with the riboprobe con-
tructs, small-scale DNA preparations were made using
he Qiaprep Spin Mini-prep Kit (Qiagen) according to the
anufacturer’s instructions. All constructs were verified
sing the T7 sequencing kit (Pharmacia). The DNA tem-
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96 NICHOLLS ET AL.plates were linearised by restriction digestions with ei-
ther EcoRI or BamHI and labeled by in vitro transcription
using the DIG RNA labeling kit (Boehringer Mannheim).
RNA–RNA in situ hybridisation
Sections on Vectabond-coated slides (Vector laborato-
ries) were dewaxed and rehydrated, washed in PBS (2 3
3 min) and encircled with a silicone pen (DAKO). The
tissues were immersed in 4% paraformaldehyde with 5
mM MgCl2 in PBS for 5 min and re-washed in PBS (2 3
min). After digestion in RNase-free DNase (15 U/ml) in
3 SSC for 1 h at 37°C in a humid chamber, the sections
ere washed in PBS (2 3 3 min) and digested in Pro-
ease K (50 mg/ml) for 15 min at 37°C. Sections were then
washed in PBS (2 3 3 min) and re-fixed as above for 5
min. After a final wash in PBS (2 3 3 min), the sections
were dehydrated through graded ethanols (30, 50, 70, 90,
and 100%, 30 s each) and air-dried. The section was
covered in RNA probe diluted 1:10 or greater in hybridi-
sation buffer [23 SSC, 5% dextran sulfate, 0.2% Marvel
(Premier Beverages), 50% deionised formamide], accord-
ing to labeling efficiency, coverslipped, and sealed with
cow gum (Cow Proofings Ltd.). Slides were incubated
overnight at 42°C.
The gum was removed and the coverslips soaked off
in 23 SSC and 0.1% SDS. Slides were washed at 55°C in
23 SSC and 0.1% SDS for 5 min then incubated in
RNAaseA (2 mg/ml in 53 SSC) for 15 min at 37°C. After
washing in 0.13 SSC and 0.04% SDS (2 3 20 min, 65°C)
and soaking in blocking buffer, sections were developed
as for DNA in situ hybridisation. Counterstains were
either Carazzi’s haematoxylin (30–45 s), or 1% aqueous
light green (60 s).
To control for false-positive signals due to nonspecific
binding of the anti-digoxigenin antibody or from nonspe-
cific precipitation of the chromogen, the RNA probe was
omitted. To control for nonspecific binding of the RNA
probe, probes of the opposite orientation (sense probes)
were used. Pre-infection tissue acted as a negative con-
trol for other false-positive signals and as a means of
FIG. 7. . Location of RNA probes relative to the COPV open reading fr
end of NCR-2 (nt5262) and near the beginning of NCR-1 (nt8369). NCRassessing the level of background signals. To prevent
binding to DNA, tissues were not subjected to heat Bdenaturation and were incubated in RNase-free DNase
to ensure that no single-stranded DNA targets were
present. Further acceptance criteria included a predom-
inantly cytoplasmic signal within epithelial cells, with no
significant signal in adjacent noninfected epithelium or
the underlying dermis.
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